HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michael Mark Selected Research
Michael Mark Research Topics
Disease
12
Type 2 Diabetes Mellitus (MODY)
12/2023 - 03/2003
8
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 05/2016
5
Neoplasms (Cancer)
05/2024 - 01/2020
5
Body Weight (Weight, Body)
07/2016 - 01/2012
4
Inflammation (Inflammations)
01/2018 - 01/2008
3
Prostatic Neoplasms (Prostate Cancer)
11/2022 - 12/2016
3
Obesity
01/2021 - 01/2012
2
Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 01/2020
2
Fibrosis (Cirrhosis)
01/2018 - 09/2014
2
Pneumonia (Pneumonitis)
12/2016 - 09/2012
2
Insulin Resistance
02/2016 - 01/2012
2
Alcoholic Fatty Liver
09/2014 - 07/2010
2
Breast Neoplasms (Breast Cancer)
03/2013 - 09/2012
2
Wounds and Injuries (Trauma)
07/2012 - 06/2005
1
Nausea
05/2024
1
Edema (Dropsy)
05/2024
1
Colitis
02/2024
1
Hepatitis
02/2024
1
Disease Progression
10/2022
1
Lung Neoplasms (Lung Cancer)
10/2022
1
Pain (Aches)
02/2021
1
Chronic Renal Insufficiency
01/2020
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2020
1
Liver Cirrhosis (Hepatic Cirrhosis)
01/2018
1
Adrenal Insufficiency (Adrenal Gland Hypofunction)
12/2016
1
Mesothelioma
12/2016
1
Malignant Mesothelioma
12/2016
1
Heart Failure
07/2016
1
Brain Neoplasms (Brain Tumor)
05/2016
1
Dyslipidemias (Dyslipidemia)
01/2016
1
Neurodegenerative Diseases (Neurodegenerative Disease)
12/2014
1
Weight Loss (Weight Reduction)
10/2014
Drug/Important Bio-Agent (IBA)
14
Linagliptin
IBA
12/2023 - 12/2007
10
Dipeptidyl-Peptidase IV Inhibitors
IBA
01/2020 - 12/2007
5
Glucose (Dextrose)
FDA Link
Generic
01/2020 - 01/2012
5
Glucagon-Like Peptide 1 (GLP 1)
IBA
10/2014 - 03/2003
3
durvalumab
IBA
02/2024 - 05/2021
3
Cisplatin (Platino)
FDA Link
Generic
10/2021 - 12/2016
3
Sodium-Glucose Transporter 2 Inhibitors
IBA
01/2020 - 01/2016
3
empagliflozin
IBA
02/2016 - 01/2014
3
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
IBA
10/2014 - 04/2008
3
Insulin (Novolin)
FDA Link
04/2014 - 03/2003
2
Creatinine
IBA
05/2024 - 01/2021
2
Docetaxel (Taxotere)
FDA Link
10/2021 - 12/2016
2
Biomarkers (Surrogate Marker)
IBA
01/2021 - 01/2018
2
Proteins (Proteins, Gene)
FDA Link
01/2021 - 12/2012
2
Sodium
IBA
02/2016 - 01/2014
2
Transcription Factors (Transcription Factor)
IBA
12/2014 - 09/2014
2
Liraglutide
FDA Link
10/2014 - 03/2003
2
Exenatide (Byetta)
FDA Link
04/2014 - 01/2012
2
Xanthine
IBA
07/2013 - 12/2007
2
Vildagliptin
IBA
02/2009 - 04/2008
2
purine
IBA
02/2009 - 04/2008
1
capmatinib
IBA
05/2024
1
Nivolumab
IBA
05/2024
1
Lipase (Acid Lipase)
FDA Link
02/2024
1
RNA (Ribonucleic Acid)
IBA
10/2022
1
Messenger RNA (mRNA)
IBA
10/2022
1
Rogaratinib
IBA
10/2022
1
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
10/2022
1
B7-H1 Antigen
IBA
05/2021
1
3-butylidene-4,5-dihydroxyphthalide (BP 42)
IBA
02/2021
1
binimetinib
IBA
01/2021
1
Pemetrexed (MTA)
FDA Link
01/2021
1
Albumins
IBA
01/2021
1
Mechanistic Target of Rapamycin Complex 1
IBA
01/2020
1
Angiotensin Receptor Antagonists
IBA
01/2020
1
Ketones
IBA
01/2020
1
lisavanbulin
IBA
01/2020
1
Prostate-Specific Antigen (Semenogelase)
IBA
01/2019
1
abiraterone
IBA
01/2019
1
Metformin (Glucophage)
FDA Link
Generic
01/2019
1
Choline (Choline Chloride)
IBA
01/2018
1
Amino Acids
FDA Link
01/2018
1
Carbon Tetrachloride (Tetrachloromethane)
IBA
01/2018
1
Lysophosphatidic Acid Receptors
IBA
01/2018
1
Tyrosine Kinase Inhibitors
IBA
01/2017
1
PM 01183
IBA
12/2016
1
orteronel
IBA
12/2016
1
Androgens
IBA
12/2016
1
Uric Acid (Urate)
IBA
07/2016
1
Sodium-Glucose Transport Proteins
IBA
07/2016
1
Carboplatin (JM8)
FDA Link
Generic
05/2016
1
Paclitaxel (Taxol)
FDA Link
Generic
05/2016
1
Symporters
IBA
02/2016
1
LDL Cholesterol
IBA
01/2016
1
Dynorphins (Dynorphin)
IBA
10/2014
1
Appetite Depressants (Anorectics)
IBA
10/2014
1
Incretins
IBA
10/2014
1
Nicotine
FDA Link
10/2014
Therapy/Procedure
8
Therapeutics
01/2021 - 07/2010
3
Castration
11/2022 - 12/2016
3
Drug Therapy (Chemotherapy)
10/2021 - 10/2010
2
Oral Administration
01/2018 - 07/2012
2
Glycemic Control
07/2016 - 02/2016
1
Immunotherapy
05/2024
1
Neoadjuvant Therapy
10/2021
1
Cranial Irradiation
01/2020
1
Combined Modality Therapy
12/2016
1
Radiotherapy
12/2016